Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Lixisenatide with Oral Anti-Diabetics in Japanese T2DM Patients
NCT01940965Phase 3Completed
- Sponsor
- Sanofi
- Start
- Sep 2013
- Primary completion
- Jul 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of lixisenatide in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Sep 2013; status: completed.
02
Drugs
lixisenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01940965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01940965.